Regeneron · 5 days ago
Sr. Scientist - Infectious Diseases
Tarrytown, NY
Full-time
Onsite
Mid, Senior Level
$110K/yr - $179K/yrRegeneron is seeking a highly skilled and motivated Sr. Scientist to contribute to antiviral immunological therapies. In this role, you will apply your immunology knowledge to progress candidate therapeutic molecules and develop novel immunological strategies to combat viral infections.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Drive research projects forward through independently designing, conducting, analyzing in vitro and in vivo experiments and through collaborative involvement
Perform T cell characterization experiments, such as cytotoxicity assays, T cell activation and cytokine release assays
Conduct different viral inhibition assay
Routinely present findings in a variety of scientific settings within and across departments
Troubleshooting methodological and technical issues
Interpreting experimental data and keeping up to date on relevant literature
Qualification
Required
Ph.D. in immunology, infectious disease, virology or related field
Strong publication record
Proven expertise in immunology or infectious disease
Experience with in vitro and in vivo experiments
Deep expertise in immunology and infectious disease experience
Comfortable tackling complex research scenarios
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Founded in 1988
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
2026-01-08
2026-01-07
Company data provided by crunchbase